Withhold judgment: “Diagnosing and judging can sometimes be confused,” noted Charnas. Do not diagnose your patient with a somatic disorder until you have exhausted all other options. “Wait until you really know the patient and withhold judgment.”

Stein agreed: “Save the SSD diagnosis for patients who are unquestionably extreme in persistent health-related concerns and activity.”


Continue Reading

Put yourself in the patient’s shoes: “We are trained as psychiatrists to be good listeners,” Stein observed. “This enables us to see things from our patients’ perspective. Listening deeply and being empathetic are the foundations of our profession.”

References

  1. Ghavidel-Parsa B, Amir Maafi A, Aarabi Y, et al. Correlation of invalidation with symptom severity and health status in fibromyalgia. Rheumatology (Oxford). 2015;54(3):482-486.
  2. Kool MB, van Middendorp H, Boeije HR, Geenen R. Understanding the lack of understanding: invalidation from the perspective of the patient with fibromyalgia. Arthritis Rheum. 2009;61(12):1650-1656.
  3. My Invisible Fight. http://invisibleillnessweek.com. Accessed: September 19, 2015.
  4. Charnas JJ. Living Well with Chronic Illness. Hollister, CA: MSI Press, 2015.
  5. American Psychiatric Association. Diagnostic and Statistical manual of Mental Disorders: DSM-5 (5th ed.). Arlington, VA: American Psychiatric Publishing, 2013.
  6. Caress SM, Steinemann AC. A national population study of the prevalence of multiple chemical sensitivity. Arch Environ Health. 2004;59(6):300-305.
  7. Francis A. The new somatic symptoms disorder in DSM-5 risks mislabeling many people as mentally ill. BMJ. 2013;346:f1580.
  8. Komaroff AL. Myalgic encephalomyelitis/chronic fatigue syndrome: a real illness. Ann Intern Med. 2015l162(12):871-872.
  9. Centers for Disease Control and Prevention (CDC). Fibromyalgia. Available at: http://www.cdc.gov/arthritis/basics/fibromyalgia.htm. Accessed: September 15, 2015.
  10. Institute of Medicine. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: redefining an illness. Washington, DC: National Academies Press, 2015. Available at: https://iom.nationalacademies.org/~/media/Files/Report%20Files/2015/MECFS/MECFS_ReportBrief.pdf. Accessed: September 23, 2015.
  11. Johannes CB, Le TK, Zhou X, et al. The prevalence of chronic pain in United States adults: results of an Internet-based survey. J Pain. 2010;11(11):1230-1239.
  12. Kreutzer R, Neutra RR, Lashuay N. Prevalence of people reporting sensitivities to chemicals in a population-based survey. Am J Epidemiol. 1999;150:1–12.
  13. Martin S, Bowes DM. Multiple chemical sensitivity: 2006 review of the evidence. Allergy, Sensitivity & Environmental Health Association Qld Inc (ASEHL). (2009). Available at: http://www.asehaqld.org.au/index.php/multiple-chemical-sensitivity/aseha-mcs-publication/78-multiple-chemical-sensitivity-2006-review-of-the-evidence?showall=1. Accessed: September 23, 2015.
  14. American Psychiatric Association (APA). Highlights of changes from DSM-IV-TR to DSM-5. Available at: http://www.dsm5.org/Documents/changes%20from%20dsm-iv-tr%20to%20dsm-5.pdf. Accessed: September 22, 2015.